Calithera Biosciences, Inc. (CALA) Financial Statements (2023 and Earlier)

Company Profile

Business Address 343 OYSTER POINT BLVD #200
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:59,537107,14660,43751,058163,79351,80071,900
Cash and cash equivalents59,537107,14660,43751,05848,47510,6016,105
Short-term investments    115,31841,18063,823
Other undisclosed cash, cash equivalents, and short-term investments     191,972
Receivables 1,5414821,9971,142  
Other undisclosed current assets1,91510,01698,87787,1972,7321,761595
Total current assets:61,452118,703159,796140,252167,66753,56172,495
Noncurrent Assets
Operating lease, right-of-use asset2,4785,754 
Property, plant and equipment5566909921,4641,759899931
Long-term investments and receivables    22,361 1,997
Long-term investments    22,361 1,997
Restricted cash and investments2704404404404404646
Other noncurrent assets  280569228290281
Other undisclosed noncurrent assets  7,260    
Total noncurrent assets:3,3046,8848,9722,47324,7881,2353,255
TOTAL ASSETS:64,756125,587168,768142,725192,45554,79675,750
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,5468,58819,62414,88110,0104,4533,833
Accounts payable3,6501,9942,0521,2471,072398562
Accrued liabilities6131,45217,57213,6348,9384,0553,271
Employee-related liabilities3,2835,142     
Deferred revenue and credits29,017  
Other undisclosed current liabilities6,4609,813     
Total current liabilities:14,00618,40119,62414,88139,0274,4533,833
Noncurrent Liabilities
Long-term debt and lease obligation1,6664,815     
Operating lease, liability1,6664,815 
Liabilities, other than long-term debt   1,1303,121437129
Deferred revenue and credits3,121437129
Deferred rent credit   1,130
Other undisclosed noncurrent liabilities(1,666)(4,815)6,718    
Total noncurrent liabilities:1,6664,8156,7181,1303,121437129
Total liabilities:15,67223,21626,34216,01142,1484,8903,962
Temporary equity, carrying amount40,702      
Stockholders' equity
Stockholders' equity attributable to parent8,382102,371142,426126,714150,30749,90671,788
Common stock8764422
Additional paid in capital499,700478,599428,479322,993300,906172,419156,353
Accumulated other comprehensive income (loss) 342(113)(270)(13)(69)
Accumulated deficit(491,326)(376,238)(286,101)(196,170)(150,333)(122,502)(84,498)
Total stockholders' equity:8,382102,371142,426126,714150,30749,90671,788
TOTAL LIABILITIES AND EQUITY:64,756125,587168,768142,725192,45554,79675,750

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues9,750187 22,25425,955  
Revenue, net25,955  
Sublease income 187 
Gross profit:9,750187 22,25425,955  
Operating expenses(125,183)(91,387)(92,895)(79,535)(55,641)(38,334)(32,819)
Other undisclosed operating loss (187)     
Operating loss:(115,433)(91,387)(92,895)(57,281)(29,686)(38,334)(32,819)
Nonoperating income (expense)
(Investment Income, Nonoperating)
(2)142897272(446)  
Other undisclosed income from continuing operations before equity method investments, income taxes 1,1082,1382,3802,306  
Loss from continuing operations before equity method investments, income taxes:(115,435)(90,137)(89,860)(54,629)(27,826)(38,334)(32,819)
Other undisclosed income from continuing operations before income taxes347      
Net loss:(115,088)(90,137)(89,860)(54,629)(27,826)(38,334)(32,819)
Other undisclosed net income attributable to parent     330175
Net loss available to common stockholders, diluted:(115,088)(90,137)(89,860)(54,629)(27,826)(38,004)(32,644)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(115,088)(90,137)(89,860)(54,629)(27,826)(38,334)(32,819)
Comprehensive loss:(115,088)(90,137)(89,860)(54,629)(27,826)(38,334)(32,819)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)(39)155157(257)386106
Comprehensive loss, net of tax, attributable to parent:(115,091)(90,176)(89,705)(54,472)(28,083)(37,948)(32,713)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: